Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen V Alderson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Nephrology and Hypertension|August 28, 2014
Where now in the management of renal artery stenosis? Implications of the ASTRAL and CORAL trialsJames Ritchie, Helen V Alderson, Philip A Kalra
International Journal of Nephrology and Renovascular Disease|March 7, 2014
Revascularization as a treatment to improve renal functionHelen V Alderson, James P Ritchie, Philip A Kalra
Emergency Medicine Journal : EMJ|May 14, 2017
An exploration of patients' experiences of participation in a randomised controlled trial of the Manchester Acute Coronary Syndromes (MACS) decision rulePatricia van den Berg, Sarah Kendal, Helen V Alderson, et al.
Nephrology (Carlton, Vic.)|May 12, 2015
Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared with other causes of chronic kidney diseaseJames Ritchie, Darren Green, Helen V Alderson, et al.
Journal of the American Society of Hypertension : JASH|January 19, 2016
Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular diseaseJames Ritchie, Darren Green, Helen V Alderson, et al.
Nephrology (Carlton, Vic.)|June 24, 2016
FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5Helen V Alderson, James P Ritchie, Rachel Middleton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 18, 2016
The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRDHelen V Alderson, James P Ritchie, Sabrina Pagano, et al.
Plos One|July 19, 2019
The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney diseaseLynne Sykes, Ozgur Asar, James Ritchie, et al.
BMC Nephrology|October 3, 2021
Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney diseaseHelen V Alderson, Rajkumar Chinnadurai, Sara T Ibrahim, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Nephrology and Hypertension|August 28, 2014
Where now in the management of renal artery stenosis? Implications of the ASTRAL and CORAL trialsJames Ritchie, Helen V Alderson, Philip A Kalra
International Journal of Nephrology and Renovascular Disease|March 7, 2014
Revascularization as a treatment to improve renal functionHelen V Alderson, James P Ritchie, Philip A Kalra
Emergency Medicine Journal : EMJ|May 14, 2017
An exploration of patients' experiences of participation in a randomised controlled trial of the Manchester Acute Coronary Syndromes (MACS) decision rulePatricia van den Berg, Sarah Kendal, Helen V Alderson, et al.
Nephrology (Carlton, Vic.)|May 12, 2015
Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared with other causes of chronic kidney diseaseJames Ritchie, Darren Green, Helen V Alderson, et al.
Journal of the American Society of Hypertension : JASH|January 19, 2016
Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular diseaseJames Ritchie, Darren Green, Helen V Alderson, et al.
Nephrology (Carlton, Vic.)|June 24, 2016
FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5Helen V Alderson, James P Ritchie, Rachel Middleton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 18, 2016
The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRDHelen V Alderson, James P Ritchie, Sabrina Pagano, et al.
Plos One|July 19, 2019
The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney diseaseLynne Sykes, Ozgur Asar, James Ritchie, et al.
BMC Nephrology|October 3, 2021
Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney diseaseHelen V Alderson, Rajkumar Chinnadurai, Sara T Ibrahim, et al.
Pageof 1